The uniformity of the batch used in biowaiver or bioavailability studies should be provided. In addition, a manufacturing process validation protocol for the validation of the first three production scale batches should be submitted. In the case where the manufacturer is already manufacturing production scale batches, then full validation data for the production of at least three consecutive production scale batches should be submitted.
